Pilot Study of the Safety and Clinical Efficacy of Topical Dermacyn™ Wound Care to Treat Mild Diabetic Foot Infections
Public ClinicalTrials.gov record NCT00516958. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open Label, Three Arm, Pilot Study of the Safety and Clinical Efficacy of Topical Dermacyn™ Wound Care vs. Oral Levofloxacin vs. Combined Therapy for Mild Diabetic Foot Infections
Study identification
- NCT ID
- NCT00516958
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Oculus Innovative Sciences, Inc.
- Industry
- Enrollment
- 65 participants
Conditions and interventions
Conditions
Interventions
- Topical Dermacyn Drug
- Topical Dermacyn and Levofloxacin Drug
- Topical Saline and Levofloxacin Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2007
- Primary completion
- Nov 30, 2007
- Completion
- Nov 30, 2007
- Last update posted
- Jan 13, 2008
2007
United States locations
- U.S. sites
- 16
- U.S. states
- 10
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Tucson | Arizona | 85710 | — |
| Not listed | La Jolla | California | 92037 | — |
| Not listed | Los Angeles | California | 90063-2326 | — |
| Not listed | San Diego | California | 92103-8896 | — |
| Not listed | Santa Rosa | California | 34669 | — |
| Not listed | Denver | Colorado | 80220 | — |
| Not listed | New Haven | Connecticut | 06515 | — |
| Not listed | Boca Raton | Florida | 33486 | — |
| Not listed | Spring Hill | Florida | 34609 | — |
| Not listed | Evansville | Indiana | 47714 | — |
| Not listed | Louisville | Kentucky | 40222 | — |
| Not listed | Boston | Massachusetts | 02215 | — |
| Not listed | Harrisburgh | Pennsylvania | 17112 | — |
| Not listed | Hazleton | Pennsylvania | 18201 | — |
| Not listed | Pittsburgh | Pennsylvania | 15224 | — |
| Not listed | Salt Lake City | Utah | 54102 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00516958, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 13, 2008 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00516958 live on ClinicalTrials.gov.